AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 95 filers reported holding AKERO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $944,000 | +317.7% | 18,665 | +284.8% | 0.00% | – |
| Q2 2023 | $226,000 | +78.0% | 4,850 | +45.9% | 0.00% | – |
| Q1 2023 | $127,000 | -56.5% | 3,325 | -37.4% | 0.00% | – |
| Q4 2022 | $292,000 | +228.1% | 5,312 | +103.9% | 0.00% | – |
| Q3 2022 | $89,000 | +304.5% | 2,605 | +9.9% | 0.00% | – |
| Q2 2022 | $22,000 | -58.5% | 2,370 | -37.5% | 0.00% | – |
| Q1 2022 | $53,000 | -67.1% | 3,793 | -50.2% | 0.00% | – |
| Q4 2021 | $161,000 | +66.0% | 7,623 | +74.6% | 0.00% | – |
| Q3 2021 | $97,000 | -2.0% | 4,365 | +9.9% | 0.00% | – |
| Q2 2021 | $99,000 | +28.6% | 3,972 | +49.8% | 0.00% | – |
| Q1 2021 | $77,000 | +60.4% | 2,652 | +44.8% | 0.00% | – |
| Q4 2020 | $48,000 | +41.2% | 1,831 | +67.8% | 0.00% | – |
| Q3 2020 | $34,000 | +25.9% | 1,091 | 0.0% | 0.00% | – |
| Q2 2020 | $27,000 | +12.5% | 1,091 | -4.3% | 0.00% | – |
| Q1 2020 | $24,000 | +41.2% | 1,140 | +53.2% | 0.00% | – |
| Q4 2019 | $17,000 | +1600.0% | 744 | +1590.9% | 0.00% | – |
| Q3 2019 | $1,000 | – | 44 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 5,830,203 | $179,512,000 | 24.20% |
| venBio Partners LLC | 2,444,311 | $75,260,000 | 11.44% |
| Versant Venture Management, LLC | 777,727 | $23,946,000 | 4.38% |
| Redmile Group, LLC | 2,336,357 | $71,936,000 | 1.32% |
| Vivo Capital, LLC | 571,833 | $17,607,000 | 1.02% |
| Cormorant Asset Management, LP | 859,550 | $26,466,000 | 1.02% |
| Boxer Capital, LLC | 831,495 | $25,602,000 | 0.88% |
| Integral Health Asset Management, LLC | 85,000 | $2,617,000 | 0.80% |
| EAM Global Investors LLC | 49,718 | $1,531,000 | 0.56% |
| Crawford Lake Capital Management, LLC | 43,826 | $1,349,000 | 0.56% |